We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Decontamination Strategies Ineffective against ICU Bloodstream Infections

By HospiMedica International staff writers
Posted on 27 Nov 2018
Print article
Neither prophylactic antibiotics nor antiseptic mouthwash significantly reduce multidrug-resistant gram-negative bloodstream infections in ventilated intensive care unit (ICU) patients, claims a new study.

Researchers at University Medical Center Utrecht (UMCU; The Netherlands), Henri Mondor University Hospital (CHU Mondor; Créteil Cede, France), Centre Hospitalier Universitaire de Liège (CHU Liege; Belgium), and ten other European ICUs conducted a randomized study to determine associations between chlorhexidine (CHX) mouthwash, selective oropharyngeal decontamination (SOD), and selective digestive tract decontamination (SDD) on the occurrence of ICU-acquired bloodstream infections.

The study was conducted from December 1, 2013 to May 31, 2017, in ICUs where at least five percent of bloodstream infections are caused by extended-spectrum β-lactamase–producing Enterobacteria. In all, 8,665 patients (median age 64.1 years; 64.2% men) with anticipated mechanical ventilation of more than 24 hours were eligible. Each ICU was randomly assigned to a six-month intervention with either CHX 2% mouthwash, a SOD mouthpaste with colistin, tobramycin, and nystatin, or an SDD with the same antibiotics, all applied four times daily to patients who were ventilated for at least 24 hours.

The results revealed that 144 of the patients experienced an ICU-acquired bloodstream infection with multidrug-resistant gram-negative bacteria (MDRGNB); 2.1% of infections occurred during the baseline period; 1.8% during CHX; 1.59% with SOD; and 1.2% with SDD. Compared with baseline, absolute risk reductions were 0.3%, 0.6%, and 0.8%, respectively. Crude morality risks on day 28 were 31.9% during baseline, 32.9% with CHX, 32.4% with SOD, and 34.1% with SDD. The study was published on October 22, 2018, in JAMA.

“In addition to lack of efficacy against bloodstream infections, there is no beneficial effect on survival of ICU patients, which is in contrast with previous studies performed in settings with lower levels of antibiotic resistance,” said lead author Bastiaan Wittekamp, MD, of UMCU. “The indication that there may be differences in the effectiveness of decontamination strategies that may depend on the level of antibiotic resistance warrants further investigations.”

Infections acquired in the ICU are important complications of the treatment of critically ill patients, increasing morbidity, mortality, and health care costs. Reductions in the incidence of respiratory tract infections have been reported using prophylactic antibiotic regimens, such as SDD and SOD. Due to concerns about increased selection of antibiotic-resistant pathogens, the routine use of SDD and SOD has remained controversial, and has not been recommended in international guidelines.

Related Links:
University Medical Center Utrecht
Henri Mondor University Hospital
Centre Hospitalier Universitaire de Liège

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Mechanical Baby Scale
seca 725

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.